By 2050, nearly 150 million are expected to be living with dementia. At present 58% of people with dementia live in low and middle-income countries (LMICs), but by 2050 [...]
In March 2019, pharmaceutical company Biogen announced the halt of its global phase-three trials testing the effectiveness of aducanumab in treating [...]
Swedish Care International is the official driver of the #BeBrainPowerful campaign in Sweden. The campaign was announced at our third biennial summit [...]